ZM: Zoom has officially topped...Short it.
Updated
I'm short 
ZM since earlier today, I believe it has peaked here. Investors are likely to take profits now that competition has increased dramatically for them.
They thrived when the world was locked down due to the threat of COVID-19, but now that vaccines will be widely available and distributed globally very soon, holding shares has become extremely risky. I'd urge everyone holding to sell and buy something oversold with proceeds...If interested in knowing what to buy now, contact me.
A short here has very low risk, I think it can last for a long time falling, so do your own due diligence with sizing to not risk more than 1-2% if it goes against you by 3 average ranges.
Cheers,
Ivan Labrie.
ZM since earlier today, I believe it has peaked here. Investors are likely to take profits now that competition has increased dramatically for them.They thrived when the world was locked down due to the threat of COVID-19, but now that vaccines will be widely available and distributed globally very soon, holding shares has become extremely risky. I'd urge everyone holding to sell and buy something oversold with proceeds...If interested in knowing what to buy now, contact me.
A short here has very low risk, I think it can last for a long time falling, so do your own due diligence with sizing to not risk more than 1-2% if it goes against you by 3 average ranges.
Cheers,
Ivan Labrie.
Note
By this week's close we may get further confirmation of the long term top in #ZM.Trade closed manually
I'm out, don't like the slowness.Decent gain.
Trade closed manually
This could be about to resume the uptrend, given the broad market trend it wouldn't shock me. Trade active
This really topped then...#ZM can drop sharply from here:
s3.amazonaws.com/tradingview/snapshots/e/En9Oqmp1.png
Note
Trade closed manually
ZM bottomed: Trade active
Short it again...Last: 60.44
🔒Want to dive deeper? Check out my paid services below🔒
ivanlabrie.substack.com/
ivanlabrie.substack.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.